Document is current
Any future updates will be listed below
-
Authors
Mohammadi-Nejad, Ali-Reza https://orcid.org/0000-0002-0710-6700
Craig, Martin https://orcid.org/0000-0003-4956-4512
Cox, Eleanor F.
Chen, Xin https://orcid.org/0000-0002-3685-0854
Jenkins, R. Gisli
Francis, Susan
Sotiropoulos, Stamatios N. https://orcid.org/0000-0003-4735-5776
Auer, Dorothee P. https://orcid.org/0000-0002-4745-3635
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (MR/W014491/1, MR/V005324/1, MR/W014491/1, MR/V005324/1, MR/W014491/1, MR/V005324/1, MR/W014491/1, MR/V005324/1)
DH | National Institute for Health Research (Nottingham Biomedical Research Centre, Nottingham Biomedical Research Centre, Nottingham Biomedical Research Centre, Nottingham Biomedical Research Centre)
European Research Council
- License Information
-
More Information
Article History
Received: 27 August 2024
Accepted: 9 June 2025
First Online: 22 July 2025
Competing interests
: R.G.J. reports research grants or contracts from AstraZeneca, Galecto, GlaxoSmithKline, Nordic Bioscience, Redx and Pliant, with all payments made to his institution. He has served as a consultant for AbbVie, AdAlta, Apollo Therapeutics, Arda Therapeutics, AstraZeneca, Brainomix, Bristol Myers Squibb, Chiesi, Cohbar, Galecto, GlaxoSmithKline, Mediar Therapeutics, Redx, Syndax and Pliant. He has received honoraria for lectures, presentations, speaker bureau participation, manuscript writing, or educational events from Boehringer Ingelheim, Chiesi, Roche and AstraZeneca. He has received payment for expert testimony from Pinsent Masons LLP. He has served on data safety monitoring boards or advisory boards for Boehringer Ingelheim, Galapagos and Vicore. He holds an unpaid advisory board role at NuMedii and serves as President of Action for Pulmonary Fibrosis. He is also Chair of the Editorial Board of BMJ Open Respiratory Research. All other authors declare no competing interests.
